Candel Therapeutics (CADL) Change in Cash: 2020-2024
Historic Change in Cash for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to $67.2 million.
- Candel Therapeutics' Change in Cash rose 58.77% to -$7.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$34.6 million, marking a year-over-year decrease of 171.90%. This contributed to the annual value of $67.2 million for FY2024, which is 294.09% up from last year.
- Per Candel Therapeutics' latest filing, its Change in Cash stood at $67.2 million for FY2024, which was up 294.09% from -$34.6 million recorded in FY2023.
- Candel Therapeutics' 5-year Change in Cash high stood at $67.2 million for FY2024, and its period low was -$34.6 million during FY2023.
- For the 3-year period, Candel Therapeutics' Change in Cash averaged around $6.6 million, with its median value being -$12.7 million (2022).
- Per our database at Business Quant, Candel Therapeutics' Change in Cash tumbled by 171.90% in 2023 and then soared by 294.09% in 2024.
- Candel Therapeutics' Change in Cash (Yearly) stood at $29.9 million in 2020, then skyrocketed by 59.83% to $47.7 million in 2021, then slumped by 126.69% to -$12.7 million in 2022, then plummeted by 171.90% to -$34.6 million in 2023, then spiked by 294.09% to $67.2 million in 2024.